Cargando…

Effects of Additional Intraoperative Administration of Sufentanil on Postoperative Pain, Stress and Inflammatory Responses in Patients Undergoing Laparoscopic Myomectomy: A Double-Blind, Randomized, Placebo-Controlled Trial

PURPOSE: Although pain after laparoscopic surgery is assumed to be minor, many women still suffer from unexpected postoperative pain. Thus, we aimed to assess whether additional intraoperative administration of sufentanil could help to improve postoperative pain and related agitation, stress, and in...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Lian, Li, Bingyu, Cao, Quan, Zhao, Bo, Gao, Wenwei, Chen, Yuan, Yu, Shihua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7468475/
https://www.ncbi.nlm.nih.gov/pubmed/32943911
http://dx.doi.org/10.2147/JPR.S257337
_version_ 1783578226498469888
author Liu, Lian
Li, Bingyu
Cao, Quan
Zhao, Bo
Gao, Wenwei
Chen, Yuan
Yu, Shihua
author_facet Liu, Lian
Li, Bingyu
Cao, Quan
Zhao, Bo
Gao, Wenwei
Chen, Yuan
Yu, Shihua
author_sort Liu, Lian
collection PubMed
description PURPOSE: Although pain after laparoscopic surgery is assumed to be minor, many women still suffer from unexpected postoperative pain. Thus, we aimed to assess whether additional intraoperative administration of sufentanil could help to improve postoperative pain and related agitation, stress, and inflammation response in patients undergoing laparoscopic myomectomy. PATIENTS AND METHODS: Forty female patients with uterine myoma scheduled for laparoscopic myomectomy under general anesthesia were randomized to receive sufentanil (group T, n=20) or normal saline (group C, n=20) 1h before the end of the surgery. The postoperative pain, agitation, stress, inflammation, and adverse effects were measured. RESULTS: As the primary outcome, the visual analog scale (VAS) pain score was significantly reduced in group T as compared with group C at each measured time point in a post-anesthesia care unit (PACU), VAS 5 min (31.5 ± 2.7 vs 40.6 ± 5.6) (P<0.001), VAS 30 min (36.5 ± 4.5 vs 46.0 ± 2.9) (P<0.001), VAS 1h (37.8 ± 4.0 vs 48.6 ± 5.5) (P<0.001). The secondary outcomes, including the sedation agitation scale (SAS) scores, plasma concentrations of epinephrine and norepinephrine, and the levels of plasma interleukin-6 (IL-6), interleukin-8 (IL-8), and tumor necrosis factor-alpha (TNF-α) in group T were remarkably lower than those in group C (P < 0.001). The cough cases in group T also showed a significant reduction in comparison with group C (P < 0.05). In addition, the anesthetic recovery time, including the spontaneous breathing recovery time and extubation time, were not significantly different between the two groups, as were the cases of respiratory depression and postoperative delirium (P > 0.05). CONCLUSION: For patients undergoing laparoscopic myomectomy, administration of sufentanil 1 h before the end of surgery shows excellent analgesic and sedative effects, alleviated postoperative stress and inflammatory responses, reduced incidence of cough, without prolonging anesthetic recovery time and increasing adverse reactions.
format Online
Article
Text
id pubmed-7468475
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-74684752020-09-16 Effects of Additional Intraoperative Administration of Sufentanil on Postoperative Pain, Stress and Inflammatory Responses in Patients Undergoing Laparoscopic Myomectomy: A Double-Blind, Randomized, Placebo-Controlled Trial Liu, Lian Li, Bingyu Cao, Quan Zhao, Bo Gao, Wenwei Chen, Yuan Yu, Shihua J Pain Res Original Research PURPOSE: Although pain after laparoscopic surgery is assumed to be minor, many women still suffer from unexpected postoperative pain. Thus, we aimed to assess whether additional intraoperative administration of sufentanil could help to improve postoperative pain and related agitation, stress, and inflammation response in patients undergoing laparoscopic myomectomy. PATIENTS AND METHODS: Forty female patients with uterine myoma scheduled for laparoscopic myomectomy under general anesthesia were randomized to receive sufentanil (group T, n=20) or normal saline (group C, n=20) 1h before the end of the surgery. The postoperative pain, agitation, stress, inflammation, and adverse effects were measured. RESULTS: As the primary outcome, the visual analog scale (VAS) pain score was significantly reduced in group T as compared with group C at each measured time point in a post-anesthesia care unit (PACU), VAS 5 min (31.5 ± 2.7 vs 40.6 ± 5.6) (P<0.001), VAS 30 min (36.5 ± 4.5 vs 46.0 ± 2.9) (P<0.001), VAS 1h (37.8 ± 4.0 vs 48.6 ± 5.5) (P<0.001). The secondary outcomes, including the sedation agitation scale (SAS) scores, plasma concentrations of epinephrine and norepinephrine, and the levels of plasma interleukin-6 (IL-6), interleukin-8 (IL-8), and tumor necrosis factor-alpha (TNF-α) in group T were remarkably lower than those in group C (P < 0.001). The cough cases in group T also showed a significant reduction in comparison with group C (P < 0.05). In addition, the anesthetic recovery time, including the spontaneous breathing recovery time and extubation time, were not significantly different between the two groups, as were the cases of respiratory depression and postoperative delirium (P > 0.05). CONCLUSION: For patients undergoing laparoscopic myomectomy, administration of sufentanil 1 h before the end of surgery shows excellent analgesic and sedative effects, alleviated postoperative stress and inflammatory responses, reduced incidence of cough, without prolonging anesthetic recovery time and increasing adverse reactions. Dove 2020-08-26 /pmc/articles/PMC7468475/ /pubmed/32943911 http://dx.doi.org/10.2147/JPR.S257337 Text en © 2020 Liu et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Liu, Lian
Li, Bingyu
Cao, Quan
Zhao, Bo
Gao, Wenwei
Chen, Yuan
Yu, Shihua
Effects of Additional Intraoperative Administration of Sufentanil on Postoperative Pain, Stress and Inflammatory Responses in Patients Undergoing Laparoscopic Myomectomy: A Double-Blind, Randomized, Placebo-Controlled Trial
title Effects of Additional Intraoperative Administration of Sufentanil on Postoperative Pain, Stress and Inflammatory Responses in Patients Undergoing Laparoscopic Myomectomy: A Double-Blind, Randomized, Placebo-Controlled Trial
title_full Effects of Additional Intraoperative Administration of Sufentanil on Postoperative Pain, Stress and Inflammatory Responses in Patients Undergoing Laparoscopic Myomectomy: A Double-Blind, Randomized, Placebo-Controlled Trial
title_fullStr Effects of Additional Intraoperative Administration of Sufentanil on Postoperative Pain, Stress and Inflammatory Responses in Patients Undergoing Laparoscopic Myomectomy: A Double-Blind, Randomized, Placebo-Controlled Trial
title_full_unstemmed Effects of Additional Intraoperative Administration of Sufentanil on Postoperative Pain, Stress and Inflammatory Responses in Patients Undergoing Laparoscopic Myomectomy: A Double-Blind, Randomized, Placebo-Controlled Trial
title_short Effects of Additional Intraoperative Administration of Sufentanil on Postoperative Pain, Stress and Inflammatory Responses in Patients Undergoing Laparoscopic Myomectomy: A Double-Blind, Randomized, Placebo-Controlled Trial
title_sort effects of additional intraoperative administration of sufentanil on postoperative pain, stress and inflammatory responses in patients undergoing laparoscopic myomectomy: a double-blind, randomized, placebo-controlled trial
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7468475/
https://www.ncbi.nlm.nih.gov/pubmed/32943911
http://dx.doi.org/10.2147/JPR.S257337
work_keys_str_mv AT liulian effectsofadditionalintraoperativeadministrationofsufentanilonpostoperativepainstressandinflammatoryresponsesinpatientsundergoinglaparoscopicmyomectomyadoubleblindrandomizedplacebocontrolledtrial
AT libingyu effectsofadditionalintraoperativeadministrationofsufentanilonpostoperativepainstressandinflammatoryresponsesinpatientsundergoinglaparoscopicmyomectomyadoubleblindrandomizedplacebocontrolledtrial
AT caoquan effectsofadditionalintraoperativeadministrationofsufentanilonpostoperativepainstressandinflammatoryresponsesinpatientsundergoinglaparoscopicmyomectomyadoubleblindrandomizedplacebocontrolledtrial
AT zhaobo effectsofadditionalintraoperativeadministrationofsufentanilonpostoperativepainstressandinflammatoryresponsesinpatientsundergoinglaparoscopicmyomectomyadoubleblindrandomizedplacebocontrolledtrial
AT gaowenwei effectsofadditionalintraoperativeadministrationofsufentanilonpostoperativepainstressandinflammatoryresponsesinpatientsundergoinglaparoscopicmyomectomyadoubleblindrandomizedplacebocontrolledtrial
AT chenyuan effectsofadditionalintraoperativeadministrationofsufentanilonpostoperativepainstressandinflammatoryresponsesinpatientsundergoinglaparoscopicmyomectomyadoubleblindrandomizedplacebocontrolledtrial
AT yushihua effectsofadditionalintraoperativeadministrationofsufentanilonpostoperativepainstressandinflammatoryresponsesinpatientsundergoinglaparoscopicmyomectomyadoubleblindrandomizedplacebocontrolledtrial